Literature DB >> 2428217

Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?

M K Church.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 2428217     DOI: 10.1007/bf01964986

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  30 in total

1.  Effect of disodium cromoglycate on exercise-induced asthma.

Authors:  S E Davies
Journal:  Br Med J       Date:  1968-09-07

2.  Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.

Authors:  J S Cox
Journal:  Nature       Date:  1967-12-30       Impact factor: 49.962

3.  Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.

Authors:  B Hegardt; R Pauwels; M Van Der Straeten
Journal:  Allergy       Date:  1981-02       Impact factor: 13.146

Review 4.  Calcium and histamine secretion from mast cells.

Authors:  F L Pearce
Journal:  Prog Med Chem       Date:  1982

5.  Site of action of the antiallergic drugs cromoglycate and doxantrazole [proceedings].

Authors:  J C Foreman; M B Hallett; J L Mongar
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

6.  Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. II. A comparison of the rat anti-dnp 7S 2 and rat reagin induced cutaneous reactions.

Authors:  T S Orr; J Gwilliam; J S Cox
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

7.  Blood histamine levels after exercise testing.

Authors:  M G Harries; P S Burge; I O'Brien; O Cromwell; J Pepys
Journal:  Clin Allergy       Date:  1979-09

8.  Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma.

Authors:  P H Howarth; S R Durham; T H Lee; A B Kay; M K Church; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1985-11

9.  Role of bronchial irritant receptors in asthma.

Authors:  M G Harries; P E Parkes; M H Lessof; T S Orr
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

10.  Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.

Authors:  G D Watt; T C Bui; A K Bewtra; R G Townley
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

View more
  2 in total

1.  Development of preclinical models for testing antiasthma drugs.

Authors:  T S Orr
Journal:  Drugs       Date:  1989       Impact factor: 9.546

2.  Effect of an inhaled mast cell stabiliser, N-acetyl-aspartyl-glutamate (Zy15109) on allergen-induced immediate bronchoconstriction.

Authors:  C K Lai; J Gregory; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.